Europe

Pfizer and BioNTech to Potentially Sell 300 Million Doses of Its Coronavirus Vaccine to EU
Pfizer and BioNTech to Potentially Sell 300 Million Doses of Its Coronavirus Vaccine to EU
Motley Fool
Pfizer
BioNTech
vaccines
BNT162b2
Europe
COVID-19
Flag link:
Ahead of merger with Pfizer's generic unit, Mylan makes $757M+ purchase for European thrombosis portfolio
Ahead of merger with Pfizer's generic unit, Mylan makes $757M+ purchase for European thrombosis portfolio
Endpoints
Mylan
Europe
generics
Aspen Pharmacare
M&A
thrombosis
Pfizer
Flag link:
Janssen gets expanded EC nod for blood cancer combo drug Imbruvica plus rituximab
Janssen gets expanded EC nod for blood cancer combo drug Imbruvica plus rituximab
Pharmaceutical Business Review
JNJ
Janssen
Europe
Imbruvica
rituximab
CLL
Flag link:
Roche to launch 40M rapid coronavirus antigen tests per month, starting in Europe
Roche to launch 40M rapid coronavirus antigen tests per month, starting in Europe
Fierce Biotech
Roche
COVID-19
diagnostics
Europe
FDA
Emergency Use Authorization
Flag link:
J&J to start mid-stage coronavirus vaccine trials in three European countries
J&J to start mid-stage coronavirus vaccine trials in three European countries
Reuters
JNJ
Janssen
vaccines
COVID-19
clinical trials
Europe
Spain
The Netherlands
Germany
Flag link:
Moderna on the verge of European supply deal for 160M doses of COVID-19 vaccine
Moderna on the verge of European supply deal for 160M doses of COVID-19 vaccine
Fierce Pharma
Moderna Therapeutics
COVID-19
vaccines
Europe
Flag link:
CureVac in 'advanced' talks with EU to supply 225M coronavirus vaccine doses
CureVac in 'advanced' talks with EU to supply 225M coronavirus vaccine doses
Fierce Pharma
CureVac
Europe
vaccines
MRNA
COVID-19
Flag link:
Could AI avert a future coronavirus pandemic?
Could AI avert a future coronavirus pandemic?
Pharmaforum
artificial intelligence
pandemic
COVID-19
Europe
Flag link:
On heels of U.S. pact, Johnson & Johnson strikes a double-size COVID vaccine deal with Europe
On heels of U.S. pact, Johnson & Johnson strikes a double-size COVID vaccine deal with Europe
Fierce Pharma
JNJ
Europe
pandemic
vaccines
COVID-19
Flag link:
Amarin spurns would-be marketing partners to launch Vascepa in Europe on its own
Amarin spurns would-be marketing partners to launch Vascepa in Europe on its own
Fierce Pharma
Amarin
Vascepa
earnings
Europe
Flag link:
Sandoz earmarks $175M to upgrade tech at European hub for antibiotics manufacturing
Sandoz earmarks $175M to upgrade tech at European hub for antibiotics manufacturing
BioPharma Dive
Novartis
Sandoz
Europe
antibiotics
drug manufacturing
Flag link:
Sanofi to move ahead with complicated API spinoff worth up to €2B: Reuters
Sanofi to move ahead with complicated API spinoff worth up to €2B: Reuters
Fierce Pharma
Sanofi
Europe
APIs
spinoffs
drug manufacturing
Flag link:
Ovid Licenses European Rights to Lead Rare Disease Drug to Angelini Pharma
Ovid Licenses European Rights to Lead Rare Disease Drug to Angelini Pharma
Xconomy
Ovid Therapeutics
Angelman Syndrome
Angelini Pharma
Europe
clinical trials
Flag link:
Forbion Continues Funding Efforts, Raises $208M for More Investments
Forbion Continues Funding Efforts, Raises $208M for More Investments
BioSpace
venture capital
Forbion
Europe
Flag link:
Propeller gets green light to bundle its digital health tools with inhalers
Propeller gets green light to bundle its digital health tools with inhalers
MedCity News
Novartis
Propeller Health
Europe
digital health
inhalers
digital therapeutics
Flag link:
Spanish Covid-19 antibody study suggests herd immunity infeasible
Spanish Covid-19 antibody study suggests herd immunity infeasible
MedCity News
Spain
COVID-19
pandemic
herd immunity
Europe
antibody tests
Flag link:
J&J’s Ebola vaccine approved in EU
J&J’s Ebola vaccine approved in EU
Pharmaforum
Europe
JNJ
ebola virus
Janssen
vaccines
Bavarian Nordic
Flag link:
Takeda takes a $200M hit after Novartis is forced to yank its marketing application for Xiidra
Takeda takes a $200M hit after Novartis is forced to yank its marketing application for Xiidra
Endpoints
Takeda
Novartis
Xiidra
Europe
EMA
dry eye disease
Flag link:
Vertex : CHMP Grants Positive Opinion For KAFTRIO - KALYDECO In People Ages 12 And Older With CF
Vertex : CHMP Grants Positive Opinion For KAFTRIO - KALYDECO In People Ages 12 And Older With CF
Business Insider
Vertex Pharmaceuticals
Europe
EMA
CHMP
cystic fibrosis
Kalydeco
Kaftrio
Flag link:
Novartis strikes out with dry eye med Xiidra in Europe
Novartis strikes out with dry eye med Xiidra in Europe
Seeking Alpha
Novartis
dry eye disease
Europe
Xiidra
CHMP
Flag link:

Pages